Product Information
SUCRALFATE 1 GM TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1725 per EA under NDC 62135043690. Its NADAC has been published 192 times since Dec 21, 2022.
FDA first approved this application on Jun 8, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Chartwell RX LLCNDC
62135043690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA074415FDA Approved
6/8/1998
TE Code
AB
On Market Since
2/17/2020
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM TABLET has been published 192 times since Dec 21, 2022, and over the history we have for it it has declined 17.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1725 per EA |
|---|---|
| All-time high | $0.2241 (Feb 14, 2024) |
| All-time low | $0.1563 (Nov 20, 2024) |
| 52-week high | $0.1905 |
| 52-week low | $0.1725 |
| Median price | $0.1875 |
| Average price | $0.1926 |
| Largest weekly change | -11.6% (Nov 20, 2024) |
| Weeks tracked | 192 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM TABLET, manufactured by Chartwell RX LLC, is $0.1725 per EA (NDC 62135043690), effective Aug 19, 2026.
How has the price of SUCRALFATE 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM TABLET has declined 17.6%. It has been tracked across 192 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM TABLET?
Since Dec 21, 2022, the NADAC for SUCRALFATE 1 GM TABLET has ranged from a low of $0.1563 (Nov 20, 2024) to a high of $0.2241 (Feb 14, 2024), with a median of $0.1875 per EA.
Are there cheaper alternatives to SUCRALFATE 1 GM TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SUCRALFATE 1 GM TABLET?
SUCRALFATE 1 GM TABLET (NDC 62135043690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.